TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT02894229

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mindfulness Based Stress Reduction
Description: A modified version of traditional MBSR. The current study's version of MBSR is shortened to 6-weeks.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive-Behavioral Therapy (CBT) Group
Description: A 6-week, 2-hour per group, skills group that focuses on various cognitive-behavioral skills for stress reduction (e.g., progressive muscle relaxation; cognitive restructuring).
Study: NCT02799108

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NIRS
Description: High-resolution EEG-fNIRS recording lasting a maximum of 30 minutes by using expressive and receptive language paradigms

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: fMRI
Description: fMRI acquisition under the same stimulation conditions
Study: NCT00615069

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 31 mm GORE EXCLUDER® AAA Endoprosthesis
Description: GORE EXCLUDER® AAA Endoprosthesis - 31 mm device implanted for the primary treatment of infrarenal abdominal aortic aneurysms (AAA)
Study: NCT04382989

Intervention type: DEVICE
Intervention: Analysis of human milk composition by mid-infrared spectrophotometry
Description: Analysis of human milk macronutrient content was performed by mid-infrared spectrophotometry using a Miris Human Milk Analyser.~An immune-enzymatic ELISA assays were used to estimate lysozyme and lactoferrin concentrations in human milk.
Study: NCT02435914

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AGN-223575 ophthalmic solution
Description: AGN-223575 ophthalmic solution once or twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AGN-223575 ophthalmic solution
Description: AGN-223575 ophthalmic solution once or twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AGN-223575 ophthalmic solution
Description: AGN-223575 ophthalmic solution once or twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AGN-223575 vehicle ophthalmic solution
Description: Vehicle to AGN22375 ophthalmic solution once or twice daily.
Study: NCT03264118

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Scaling and root planing
Description: Furcation treatment by scaling and root planing

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Scaling and root planing
Description: Furcation treatment by scaling and root planing

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toluidine Blue O
Description: Antimicrobial photodynamic therapy with toluidine blue O (10mg/ml) and red laser.
Study: NCT04143178

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Expressive Writing
Description: The expressive writing is a form of writing therapy developed primarily by James W. Pennebaker in the late 1980s consisting of writing about stressful and traumatic experience for 15-20 min for 3 consecutive days, including one's thoughts and feelings. The expressive writing allows people to express and process emotions, feelings, and thoughts related to the life events and consequent changes and this may favor a mental reorganization of the negative events, a greater expression and regulation of the emotions related to them. This intervention could provoke social, emotional, and consequently, psychophysical changes as is showed in patients with chronic diseases and cancer. In the present study, to all participants in the writing group, 5 days after the transplant, has been asked to write for 3 consecutive days, 20 minutes each days about their deepest emotions and feelings related to the chronic failure, the transplant and their expectations after that.

Intervention type: OTHER
Group type: OTHER
Intervention: Neutral Writing
Description: Five days after the transplant, to the control group participants has been asked to write for 3 consecutive days 20 minutes a day on an assigned neutral theme (eg. describe 1 object in the room) as objectively as possible, without mentioning their emotions or thoughts related to it.
Study: NCT02482831

Intervention type: PROCEDURE
Intervention: Subgluteal sciatic nerve block
Description: All patients (either diabetic or non-diabetic patients) received an ultrasound-guided (nerve stimulator assisted) subgluteal sciatic nerve block with 0.75% ropivacaine 20ml.

Intervention type: PROCEDURE
Intervention: Subgluteal sciatic nerve block
Description: All patients (either diabetic or non-diabetic patients) received an ultrasound-guided (nerve stimulator assisted) subgluteal sciatic nerve block with 0.75% ropivacaine 20ml.
Study: NCT02084251

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PB-119
Study: NCT02435914

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AGN-223575 vehicle ophthalmic solution
Description: Vehicle to AGN22375 ophthalmic solution once or twice daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AGN-223575 vehicle ophthalmic solution
Description: Vehicle to AGN22375 ophthalmic solution once or twice daily.
Study: NCT04234256

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Static stretching exercise
Description: Standing quadriceps stretch, Gastrocnemius stretch, Standing split, Adductor stretch, Half kneeling groin stretch, Hamstring stretch on the bench, Prayer squat, Seated adductor and hamstring stretch, Hurdle seat, Seated glute stretch, Lying glute stretch, Seated groin abduction, Soleus stretch, Half kneeling quad stretch, Split hamstring stretch

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dynamic stretching exercise
Description: Downward dog to runner's lunge, Dynamic squat stretch, Crescent to hamstring stretch, Half kneeling hamstring stretch, Side to side lunge with reach, Standing calf and hamstring stretch, Hurdles, Side to side lunge with step, IT band stretch, Walking quad stretch, Swing the leg forward and back, Swing the leg cross, Knee pull, Standing quat stretch, Standing gluteus stretch
Study: NCT04121364

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tetranite
Description: Dental Adhesive for increased implant stability
Study: NCT04507425

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care - Nasal Cannula
Description: Standard of care. Flexible tube to provide extra oxygen when patients need a little help, but are not in respiratory distress.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care - Nasal Cannula
Description: Standard of care. Flexible tube to provide extra oxygen when patients need a little help, but are not in respiratory distress.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High-flow nasal cannula
Description: Same as nasal cannula, except the oxygen is heated or humidified and the flow is stronger, pushing air into the lungs to help keep the airway open.
Study: NCT02435914

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: AGN-223575 vehicle ophthalmic solution
Description: Vehicle to AGN22375 ophthalmic solution once or twice daily.
Study: NCT03038347

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Training
Description: Six modules containing PDF-files with text-based information, video files, case studies with associated questions and practical exercises. Participants can download the modules and associated materials from an online platform they need to register for. They receive access to modules and associated exercises once a week. After six weeks the training is completed.
Study: NCT04507425

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High-flow nasal cannula
Description: Same as nasal cannula, except the oxygen is heated or humidified and the flow is stronger, pushing air into the lungs to help keep the airway open.
Study: NCT00348608

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: iodixanol
Study: NCT04507425

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: HFNC plus non-invasive ventilation
Description: This method uses HFNC as described above and adds noninvasive ventilation which is similar to CPAP machine and uses a mask rather than having to intubate (putting a tube down your throat to keep your airway from collapsing).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: HFNC plus non-invasive ventilation
Description: This method uses HFNC as described above and adds noninvasive ventilation which is similar to CPAP machine and uses a mask rather than having to intubate (putting a tube down your throat to keep your airway from collapsing).
Study: NCT02433106

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: GAA 15
Description: Neuromuscular injury prevention training

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Usual training
Study: NCT01135927

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: insulin degludec
Description: NN1250 (insulin degludec) injected s.c. (under the skin) once daily for 6 days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: insulin detemir
Description: Insulin detemir injected s.c. (under the skin) once daily for 6 days
Study: NCT02072486

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sorafenib Tosylate
Description: Given PO
Study: NCT01851577

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Foundations coparenting program
Description: Family Foundations is a coparenting program for new mothers and fathers designed to teach them skills needed to parent together effectively and facilitate healthy child development. Family Foundations will be administered concurrently with home visiting.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Home visiting
Description: Home visiting is a child abuse prevention approach for new mothers designed to strengthen protective factors and mitigate risk factors in order to promote optimal child development.
Study: NCT00535860

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Teriparatide
Description: Daily for 96 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teriparatide
Description: Daily for 96 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teriparatide
Description: Daily for 96 days
Study: NCT00681356

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 4975, 15 and 5 mg
Description: Direct instillation into the surgical site

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Comparator
Description: Direct instillation into the surgical site
Study: NCT00336479

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telaprevir
Description: tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telaprevir
Description: tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Telaprevir
Description: tablet
Study: NCT03038347

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Education only
Description: Six modules containing only PDF-files with text-based information. Participants can download the modules and associated materials from an online platform they need to register for. They receive access to modules once a week. After six weeks the education is completed.
Study: NCT04586829

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Diet
Description: \<50 grams of total carbohydrates per day. Monosaturated fats consumption will be encouraged over saturated fats.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diet
Description: \<50 grams of total carbohydrates per day. Monosaturated fats consumption will be encouraged over saturated fats.
Study: NCT00336479

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ribavirin
Description: tablet
Study: NCT00681356

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 4975 - 5 mg
Description: Direct instillation into the surgical site
Study: NCT00502203

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: AUC 5 By Vein Over 1 Hour Every 21 Days for 6 Courses

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: 175 mg/m\^2 By Vein Over 3 Hours Every 21 Days for 6 Courses
Study: NCT02505529

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistance Exercise Training
Description: Behavioral interventions of resistance exercise

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mental Imagery
Description: Behavioral intervention of mental imagery
Study: NCT02476318

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ArterX Vascular Sealant
Study: NCT03640832

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Developmental Serum
Description: A 30millilitre (mL) bottle with a piston pump will be dispensed to the participants, to be used as a topical dermal (facial) application, twice daily as per normal home use.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physiogel Calming Relief Anti-Redness Serum
Description: A 30mL bottle with a piston pump will be dispensed to the participants, to be used as a topical dermal (facial) application, twice daily as per normal home use.
Study: NCT01911026

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reinforcement Nurse Education
Description: The investigational, or experimental arm, will receive standard written instructions on preparing for a colonoscopy plus instructions from reinforcement educated nurse
Study: NCT03498157

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: The exercise intervention is an at least 2 weeks lasting (till the day surgery is taking place) 5-times weekly resistance training intervention combined with aerobic exercise (mostly walking).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: The exercise intervention is an at least 2 weeks lasting (till the day surgery is taking place) 5-times weekly resistance training intervention combined with aerobic exercise (mostly walking).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Prehabilitation Education
Description: Participate will receive a 2 hour group-based prehabilitation class which will be held at the Penn State Cancer Institute, Hershey

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Prehabilitation Education
Description: Participate will receive a 2 hour group-based prehabilitation class which will be held at the Penn State Cancer Institute, Hershey

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prehabilitation Education
Description: Participate will receive a 2 hour group-based prehabilitation class which will be held at the Penn State Cancer Institute, Hershey
Study: NCT01318122

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alogliptin and pioglitazone
Description: Alogliptin 12.5 mg, tablets, orally, once daily and Pioglitazone 15 mg or 30 mg, tablets, orally, once daily for up to 40 weeks.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alogliptin and pioglitazone
Description: Alogliptin 25 mg, tablets, orally, once daily and Pioglitazone 15 mg or 30 mg, tablets, orally, once daily for up to 40 weeks.
Study: NCT03573713

Intervention type: OTHER
Group type: OTHER
Intervention: Care Groups
Description: The Care Groups model has strong evidence of improvement of maternal and child health and maternal hygiene/nutrition behaviors.Through Care Groups, women will learn about proper water, sanitation, and hygiene behaviors; Infant and Young Child Feeding practices; management of childhood illnesses; home management, referral and care seeking for sick children; family planning; and use of preventive services available at health facilities (e.g., growth monitoring, deworming, vitamin A supplementation). All children under five years of age will also be screened for acute malnutrition by the Care Group Volunteers, and receive deworming medication and vitamin A supplementation twice a year through the Ministry of Health and Community Health Workers as part of national campaigns.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: IPT-G
Description: IPT-G is an effective, low-cost, short-duration community-based method for decreasing depression has been established that was first rigorously tested in Uganda. Several Private Voluntary Organizations in Africa have used this low-cost, short-duration, community-based group psychosocial approach and found it to be a culturally-sensitive, acceptable, and feasible approach to address depression.~IPT-G treatment spans 12 weeks of treatment, consisting of 3 phases (early, middle, and termination). Within this treatment, participants are also assessed for symptoms of depression every week.
Study: NCT01319604

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SENSIMED Triggerfish
Description: Soft contact lens-based device for the continuous monitoring of IOP fluctuations

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SENSIMED Triggerfish
Description: Soft contact lens-based device for the continuous monitoring of IOP fluctuations

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SENSIMED Triggerfish
Description: Soft contact lens-based device for the continuous monitoring of IOP fluctuations

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SENSIMED Triggerfish
Description: Soft contact lens-based device for the continuous monitoring of IOP fluctuations

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SENSIMED Triggerfish
Description: Soft contact lens-based device for the continuous monitoring of IOP fluctuations

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SENSIMED Triggerfish
Description: Soft contact lens-based device for the continuous monitoring of IOP fluctuations

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SENSIMED Triggerfish
Description: Soft contact lens-based device for the continuous monitoring of IOP fluctuations
Study: NCT02170116

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIBR 1048 MS dose 1

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIBR 1048 MS dose 2

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIBR 1048 MS dose 3

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIBR 1048 MS dose 4

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIBR 1048 MS dose 5

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo to BIBR 1048 MS
Study: NCT01319604

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SENSIMED Triggerfish
Description: Soft contact lens-based device for the continuous monitoring of IOP fluctuations

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tonometer
Description: Tonometric assessment of IOP
Study: NCT03614208

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home-care rehabilitation group (HCRG)
Description: The exercise program consists of aerobic exercise on a stationary bike, muscular endurance training of the upper limb and stretching exercises for finger joint motion. The exercise on the stationary bike and muscular endurance training will be performed on alternate days, three times a week.
Study: NCT03891797

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy
Description: Group-based psychotherapy.
Study: NCT03312569

Intervention type: PROCEDURE
Intervention: Right Colectomy with Intracorporeal Anastomosis
Description: With the patient under general anesthesia, pneumoperitoneum is achieved by a method of choice of the operating surgeon. Port Placement is completed as per the standard of care. Dissection is performed and the ileocolic vessels are identified. The right mesocolon is mobilized and the ileal mesentery is divided. The transverse colon and ileum are then divided with the stapler. Next, attention is turned to constructing the anastomosis. For this purpose, the terminal ileum and the transverse colon stump are brought together. A colotomy and ileostomy is created to form a common channel. The common enterotomy is then closed as per the surgeon's standard of care. The specimen is extracted through an off-midline incision (muscle splitting transverse incision, Pfannenstiel).

Intervention type: PROCEDURE
Intervention: Right Colectomy with Extracorporeal Anastomosis
Description: With the patient under general anesthesia, pneumoperitoneum is achieved by a method of choice of the operating surgeon. Port Placement is completed as per the standard of care. Dissection is performed and the ileocolic vessels are identified. Intracorporeal devascularization may be performed at the surgeon's discretion. The gastrocolic ligament is taken down and the hepatic flexure is mobilized. After complete mobilization of the right colon, the midline incision is extended to serve as the extraction site. The specimen is delivered through the midline extraction incision and the anastomosis is conducted in a standard open technique. The two cut ends of the bowels are aligned for extracorporeal anastomosis.
Study: NCT01857609

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Study: NCT03542032

Intervention type: OTHER
Group type: OTHER
Intervention: i-gel placement maneuvers
Description: the i-gel was inserted with triple airway maneuver (mouth opening, head extension and jaw thrust) In the classic maneuver , the index finger used as a guide, pushes the back of i-gel towards the hard palate, inserting it into the pharynx till a resistance is felt and the i-gel is then fixed it its place.
Study: NCT01423188

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RVX000222
Description: capsule, 200 mg, administer with food, 100 mg twice daily 10-12 hrs apart, 24 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo RVX000222
Description: capsule, administer with food, twice daily 10-12 hrs apart, 24 weeks
Study: NCT01857609

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin and Pantoprazole

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin and Rabeprazole
Study: NCT02509091

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bronchoalveolar Lavage and Local Amikacin Injection
Description: injecting 0.4g of AK in 100 ml to 250 ml, not exceeding 300 ml. And generally, repeat it for 3 to 5 times.
Study: NCT02136888

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ponesimod Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ponesimod Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin Placebo
Study: NCT03446456

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Arginine vasopressin
Description: Intranasal vasopressin will be administered shortly before the fMRI experiment.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Intranasal saline will serve as a placebo for participants in the Saline Arm
Study: NCT02136888

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ponesimod 10 mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ponesimod 20 mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ponesimod 40 mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ponesimod 60 mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ponesimod 80 mg